Results 181 to 190 of about 1,035,200 (203)

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, Peter Willeit, Pei Gao
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

New England Journal of Medicine, 1987
W M Linehan
exaly  

Interleukin 4

Reactions Weekly, 1994
openaire   +1 more source

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Interleukin-4

2008
openaire   +1 more source

Interleukin-1 and neuronal injury

Nature Reviews Immunology, 2005
Stuart Allan
exaly  

Interleukin-4

2011
openaire   +1 more source

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Philip J Mease, Bruce W Kirkham, Arthur Kavanaugh   +2 more
exaly  

Interleukin-4

2012
openaire   +1 more source